Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer Industry Satellite Symposia

Improved patient outcomes with next-generation HER2-targeted ADCs (ID 341)

Lecture Time
16:20 - 16:35
Speakers
  • V. Mueller (Hamburg, Germany)
Session Name
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00